Related Experiment Video
Updated: Aug 23, 2025

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
596
Disparities in Treatment for Differentiated Thyroid Cancer
Stephanie Davis1, Timothy M Ullmann1, Sanziana Roman1
1Department of Surgery, University of California San Francisco, San Francisco, California, USA.
Thyroid : Official Journal of the American Thyroid Association
|November 4, 2022
Summary
Disparities in differentiated thyroid cancer (DTC) care exist for vulnerable populations in the US. Addressing these requires improving access to specialists, guideline-directed therapies, and reducing financial burdens.
Area of Science:
- Oncology
- Health Services Research
- Health Disparities
Background:
- Differentiated thyroid cancer (DTC) diagnosis and treatment disparities are documented.
- Vulnerable populations face significant challenges in DTC care.
Purpose of the Study:
- To review recent literature on DTC diagnostic and treatment disparities in the US.
- To propose solutions for improving care gaps in DTC.
Main Methods:
- Comprehensive literature review of key articles on DTC.
- Focus on disparities in treatment, diagnosis, and outcomes for disadvantaged groups.
Main Results:
- Vulnerable patients (socioeconomically disadvantaged, uninsured, rural, elderly, minorities) often present with advanced DTC.
- These groups experience reduced access to high-volume surgeons, less guideline-adherent care, and more financial toxicity.
Conclusions:
- Multifaceted approaches are needed to rectify DTC care disparities.
- Solutions include enhancing specialist access (telehealth), ensuring language-concordant care, promoting guideline adherence, and reducing treatment costs.
Keywords:
differentiated thyroid cancerdisparitiesequityinsurance statusraceradioactive iodinesexsurgical treatmentMore Related Videos
Related Concept Videos
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer
49.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.2K

